Ascentage Pharma Group International ADR (AAPG): Next-Year EPS Estimate 71.49%
As of 2026-07-17, Ascentage Pharma Group International ADR (AAPG) has a next-year EPS growth estimate of 71.49%.
On 2026-07-17, analyst consensus for AAPG's next-year EPS growth shifted from 68.34% to 71.49% — a positive change of 3.15 percentage points. Current-year growth is projected at 54.88%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 71.49%
- EPS growth this year
- 54.88%
- EPS next quarter (est)
- -$0.30
- Last price
- $18.74
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 71.49% | 54.88% | -$0.30 | $18.74 |
| 2026-07-16 | 68.34% | 56.60% | -$0.30 | $20.40 |
| 2026-07-15 | 68.34% | 56.60% | -$0.30 | $20.18 |
| 2026-07-14 | 68.34% | 56.60% | -$0.30 | $19.24 |
| 2026-07-13 | 68.34% | 56.60% | -$0.30 | $19.60 |
| 2026-07-12 | 75.00% | 52.96% | -$0.30 | $19.97 |
| 2026-07-09 | 75.00% | 52.96% | -$0.30 | $18.90 |
| 2026-07-08 | 75.00% | 52.96% | -$0.30 | $18.86 |
| 2026-07-07 | 75.00% | 52.96% | -$0.30 | $18.68 |
| 2026-07-06 | 74.86% | 52.87% | -$0.31 | $19.37 |
| 2026-07-05 | 74.86% | 52.87% | -$0.31 | $18.50 |
| 2026-07-02 | 62.70% | 49.94% | -$0.31 | $18.50 |
| 2026-07-01 | 62.70% | 49.94% | -$0.31 | $17.96 |
| 2026-06-30 | 62.70% | 49.94% | -$0.31 | $17.56 |
| 2026-06-29 | 61.79% | 48.61% | -$0.31 | $17.70 |
| 2026-06-28 | 61.79% | 48.61% | -$0.31 | $16.77 |
| 2026-06-25 | 61.79% | 48.61% | -$0.31 | $17.05 |
| 2026-06-24 | 61.79% | 48.61% | -$0.31 | $17.08 |
| 2026-06-23 | 61.79% | 48.61% | -$0.31 | $17.01 |
| 2026-06-22 | 61.79% | 48.61% | -$0.31 | $17.13 |
| 2026-06-21 | 61.79% | 48.61% | -$0.31 | $17.12 |
| 2026-06-18 | 61.79% | 48.61% | -$0.31 | $17.12 |
| 2026-06-17 | 60.26% | 49.12% | -$0.31 | $17.09 |
| 2026-06-16 | 60.26% | 49.12% | -$0.31 | $17.01 |
| 2026-06-15 | 60.26% | 49.12% | -$0.31 | $17.34 |
| 2026-06-14 | 60.26% | 49.12% | -$0.31 | $17.60 |
| 2026-06-11 | 60.26% | 49.12% | -$0.31 | $17.11 |
| 2026-06-10 | 60.26% | 49.12% | -$0.31 | $17.32 |
| 2026-06-09 | 60.92% | 46.69% | -$0.51 | $17.07 |
| 2026-06-08 | 60.92% | 46.69% | -$0.51 | $17.12 |
Recent News
- Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual MeetingGlobeNewswire
- Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business UpdatesGlobeNewswire
- Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026GlobeNewswire
- Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026GlobeNewswire
- Ascentage Pharma to Participate in Three Upcoming Investor ConferencesGlobeNewswire
- Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 TargetInsider Monkey
- Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026GlobeNewswire
- Ascentage Pharma Receives Clearance from Chinas CDE for New DrugExec Edge
- Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288GlobeNewswire
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Ascentage Pharma Group International ADR's next-year EPS growth estimate?▾
As of 2026-07-17, Ascentage Pharma Group International ADR (AAPG) has a next-year EPS growth estimate of 71.49%, based on analyst consensus.
When was the latest EPS estimate revision for AAPG?▾
The most recent revision occurred on 2026-07-17, when analysts adjusted the next-year EPS growth estimate from 68.34% to 71.49%.
What sector and industry does Ascentage Pharma Group International ADR belong to?▾
Ascentage Pharma Group International ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AAPG appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ascentage Pharma Group International ADR (AAPG) appears here because it was detected by our daily top-EPS-revision-performer screen.